Pharma Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
CMC, India
Leflunomide is possible alternative for gangciclovir sensitive and resistant CMV infection
July 4th, 2006
Leflunomide is a possible alternative for gangciclovir sensitive and resistant cytomegalovirus infection. "The search for newer more cost effective treatments for infectious diseases remains a challenge. Cytomegalovirus (CMV) infection, which is especially common in the immunosuppressed, is an important challenge for treating physicians," researchers in India report. According to the authors, "Gangciclovir's cost is a major hurdle in developing countries. Leflunomide is cheaper and is easily given orally. It works by a novel mechanism inhibiting virion assembly. "It also has immunosuppressive properties," and has "been shown to be...
Source: Pharma Law Weekly (2006-07-04)
|
